Phospho-CDK1(Y15) Polyclonal Antibody

Phospho-CDK1(Y15) Polyclonal Antibody

Introducing the PHOSPHO-CDK1(Y15) Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate accurate and reliable detection of phosphorylated cyclin-dependent kinase 1 at tyrosine 15 residue. This meticulously crafted antibody is meticulously developed using state-of-the-art techniques, ensuring exceptional specificity and sensitivity in various applications.

The PHOSPHO-CDK1(Y15) Polyclonal Antibody is meticulously produced through a rigorous process, starting with the selection of high-quality immunogens. These immunogens are carefully chosen to target the phosphorylated tyrosine 15 residue of cyclin-dependent kinase 1, guaranteeing optimal recognition and binding affinity. The antibody is then purified using advanced purification methods, resulting in a highly pure and concentrated product.

This polyclonal antibody exhibits exceptional performance in a wide range of applications, including western blotting, immunohistochemistry, and immunofluorescence. Its superior specificity enables precise detection of phosphorylated cyclin-dependent kinase 1 at tyrosine 15 residue, facilitating accurate analysis of cell cycle regulation and related cellular processes.

The PHOSPHO-CDK1(Y15) Polyclonal Antibody is characterized by its remarkable sensitivity, allowing for the detection of low abundance phosphorylated cyclin-dependent kinase 1. This attribute is particularly advantageous in studies requiring minimal sample amounts or when investigating subtle changes in protein phosphorylation levels.

Furthermore, this antibody demonstrates excellent reproducibility and reliability, ensuring consistent and robust results across experiments. Its versatility and compatibility with various sample types, including cell lysates and tissue sections, make it an indispensable tool for researchers in diverse fields, such as cancer biology, cell signaling, and drug discovery.

In summary, the PHOSPHO-CDK1(Y15) Polyclonal Antibody represents a breakthrough in scientific research, offering unparalleled specificity, sensitivity, and reliability. With its exceptional performance and broad applicability, this antibody is poised to revolutionize the study of phosphorylated cyclin-dependent kinase 1 and contribute to advancements in understanding cellular processes and disease mechanisms.